What development phase is Duperan in?

Duperan is FDA-approved (marketed).

What is the generic name of Duperan?

CLOMETACIN is the generic (nonproprietary) name of Duperan.

Last reviewed 2026-04-20 · How we verify

Duperan (CLOMETACIN)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic name	CLOMETACIN
Drug class	clometacin
Target	Prostaglandin-H2 D-isomerase
Modality	Small molecule
Therapeutic area	Pain
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Duperan CI brief — competitive landscape report
Duperan updates RSS · CI watch RSS